POLYPEPTIDE LABORATORIES A/S: Financial statements 2013
CVR: 19056201
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 16,605,000 and a net result of DKK 4,939,000. Equity in the 2013 report amounted to DKK 57,326,000. The solvency ratio was 88.1%. The company had 31 employees in the financial year.
- Gross Profit
- DKK 16,605,000
- Profit/Loss
- DKK 4,939,000
- Equity
- DKK 57,326,000
- Total Assets
- DKK 65,063,000
- Employees
- 31
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of June 15, 2013, Jens Fricke is registered as adm. dir. of POLYPEPTIDE LABORATORIES A/S.
As of June 14, 2013, Alain Scarso has stepped down as adm. dir. of POLYPEPTIDE LABORATORIES A/S.
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2012.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.